It can be easy to get your hopes up about exciting new research or alternative approaches to cancer treatment. Here's an insider's guide for figuring out which ones are worth your time.

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

The clinics have popped up all over the country, but doctors still don't know the best way to treat these patients, whose symptoms can vary dramatically.

A partnership to increase clinical trial diversity is backed by one of the nation's largest drug company trade groups.

Parents who have enrolled their children in these studies say the risk is worth it for the greater good.

Researchers are trying to learn more about COVID-19 vaccines from original study participants. The quest is hampered because many people who first received a placebo shot are opting for the vaccine.

More than 1 million adult Georgians have had at least one dose of a coronavirus vaccine made either by Pfizer or Moderna. But the vaccines haven’t yet been tested on kids. Now parents can decide whether to enroll their adolescent children in clinical trials of COVID-19 vaccines. GPB’s Ellen Eldridge reports.

Merck, which previously made an Ebola vaccine, had been seen as a serious contender in the worldwide race to come up with an answer to the coronavirus.